PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
9 hedge funds and large institutions have $3.42M invested in Provention Bio, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
9
Holders Change
+9
Holders Change %
–
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$2.86M |
| 2 |
DIM
2
DC Investments Management
Mclean,
Virginia
|
$164K |
| 3 |
3
HighTower Advisors
Chicago,
Illinois
|
$141K |
| 4 |
4
Goldman Sachs
New York
|
$88K |
| 5 |
5
BlackRock
New York
|
$84K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $2.86M | 712,902 | +712,902 | New |
|
|
DIM
2
DC Investments Management
Mclean,
Virginia
| $164K | 40,950 | +40,950 | New |
|
|
3
HighTower Advisors
Chicago,
Illinois
| $141K | 35,047 | +35,047 | New |
|
|
4
Goldman Sachs
New York
| $88K | 21,900 | +21,900 | New |
|
|
5
BlackRock
New York
| $84K | 20,763 | +20,763 | New |
|
|
BCM
6
BlueCrest Capital Management
St Helier,
Jersey
| $45K | 11,294 | +11,294 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $21K | 5,172 | +5,172 | New |
|
8
UBS Group
Zurich,
Switzerland
| $11K | 2,850 | +2,850 | New |
|
9
Morgan Stanley
New York
| $2K | 534 | +534 | New |
|
|
CFGS
10
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|